EQUIBALANCE 1,5% Peritoneal dialysis solution

Зміст інструкції

1. equibalance 4.25% glucose, 1.75 mmol/l calcium, peritoneal dialysis solution
   1. What is equibalance and what is it used for
   2. What you need to know before using equibalance
   3. How to use equibalance
   4. Solution Preparation
   5. Preparation for bag exchange
   6. Drainage
   7. Flushing
   8. Infusion
   9. Safety Position
   10. Closing the DISCO
   11. Possible side effects
   12. How to store equibalance
   13. Contents of the pack and other information
   14. What is equibalance and what is it used for
   15. What you need to know before using equibalance
   16. How to use equibalance
   17. Preparation of the solution
   18. Preparation for bag exchange
   19. Drainage
   20. Flushing
   21. Infusion
   22. Safety Position
   23. Disconnection
   24. DISCO Closure
   25. Possible side effects
   26. How to store equibalance
   27. Contents of the pack and other information
   28. What is equibalance and what is it used for
   29. What you need to know before using equibalance
   30. How to use equibalance
   31. Preparation of the solution
   32. Preparation for sac exchange
   33. Drainage
   34. Flushing
   35. Infusion
   36. Safety position
   37. Disconnection
   38. DISCO Closure
   39. Possible side effects
   40. How to store equibalance
   41. Contents of the pack and other information

equibalance 4.25% glucose, 1.75 mmol/l calcium, peritoneal dialysis solution

contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor, pharmacist or nurse.
• This medicine is prescribed only for you. Do not give it to other people, even if they have the same symptoms as you, as it could be dangerous.
• If any side effect occurs, including those not listed in this leaflet, tell your doctor, pharmacist or nurse. See section 4.

Contents of this leaflet:

• 1. What equibalanceis and what it is used for
• 2. What you need to know before you use equibalance
• 3. How to use equibalance
• 4. Possible side effects
• 5. How to store equibalance
• 6. Contents of the pack and other information

1. What is equibalance and what is it used for

equibalanceis used for blood purification through the peritoneum in patients with
end-stage chronic renal failure. This type of blood purification is called peritoneal
dialysis.

2. What you need to know before using equibalance

Do not use equibalance 4.25% glucose, 1.75 mmol/l calcium:

• If your blood potassium level is very low
• If your blood calcium level is very high
• If you suffer from decreased body fluids
• If you suffer from hypotension
• If you have a metabolic disorder known as lactic acidosisPeritoneal dialysis should not be undertaken if you suffer from: alterations in the abdominal regionsuch as: surgical interventions or abdominal injuries, burns, extensive inflammatory conditions of the abdominal wall, inflammation of the peritoneum, weeping wounds that do not heal, umbilical, inguinal or diaphragmatic hernias, tumors in the abdomen or intestine

inflammatory bowel diseases,
intestinal obstruction
lung diseases, especially pneumonia
blood poisoning caused by bacteria
very high levels of lipids in the blood
in cases of accumulation of uremic toxins in the blood (whose elimination cannot be effected
with dialysis
severe malnutrition and weight loss, especially if adequate intake of
protein-containing foods is not possible.

Warnings and precautions
Immediately inform your doctor

• if you have had a severe loss of electrolytes (salts)due to vomiting and/or diarrhea,
• If you suffer from enlarged kidneys(polycystic kidneys)
• If you suffer from inflammation of the peritoneum, recognizable by cloudy dialysate fluid and/or abdominal pain. Show the bag containing the dialysate fluid to your doctor.
• if you have severe abdominal pain, abdominal distension or vomiting. This may be a sign of encapsulating peritoneal sclerosis, a complication of peritoneal dialysis therapy that can be fatal.

During peritoneal dialysis, a loss of proteinsand water-soluble vitaminsmay occur. To avoid
imbalances, an adequate diet or the intake of supplements is recommended.
Your doctor will monitor your electrolyte (salt) levels, kidney function, body weight and nutritional status.
Due to the high glucose concentration, equi balance4.25% glucose, 1.75 mmol/l calcium
must be used with caution and under medical supervision.

Other medicines andequibalance
Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicine.
Since peritoneal dialysis can affect the effects of other drugs, your doctor may change their
dosage, especially in the case of:

• drugs for heart problems, such as digoxin. The doctor will monitor potassium levels in the blood and, if necessary, take appropriate measures.
• drugs that affect calcium levelssuch as those containing calcium or vitamin D.
• drugs that increase urine output, such as diuretics.
• drugstaken orally that lower blood sugar levels or insulin. Your blood sugar should be checked regularly. Diabetic patients may need an adjustment of their daily insulin dose.

Pregnancy and breastfeeding
If you are pregnant, suspect or are planning a pregnancy, or if you are breastfeeding with
breast milk, ask your doctor for advice before taking this medicine. There are no adequate data
on the use of equibalancein pregnant women or during breastfeeding. If
you are pregnant or breastfeeding you can use equibalance only if your doctor considers it
absolutely necessary.

Driving and operating machinery
equibalancedoes not alter or negligibly alters the ability to drive vehicles or operate
machinery.

3. How to use equibalance

Use this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, consult your doctor or pharmacist.
Your doctor will define the method, duration and frequency of use, the volume of solution and the time
of dwell in the peritoneal cavity.
If you experience tension in the abdominal region, your doctor may reduce the volume.

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Adults:the usual dose is 2,000-3,000 ml of solution four times a day depending on body
weight and renal function.
After 2-10 hours of dwell time, the solution is drained.

Children:the doctor will determine the required dialysis solution volume based on tolerance,
age, and the child's body surface area.
The recommended initial dose is 600-800 ml/m (up to 1,000 ml/m during the night) of body
surface area 4 times a day.

Automated Peritoneal Dialysis (APD)
For this dialysis, sleep•safeor Safe•Lock delivery systems are used. The exchange
of bags is automatically controlled by the equipment during the night.

• Adults: The usual prescription is 2,000 ml (maximum 3,000 ml) per exchange with 3-10 exchanges during the night and connection time to the equipment of 8-10 hours, and one or two exchanges during the day.
• Children: The volume per exchange should be 800-1,000 ml/m (up to 1,400 ml/m) of body surface area with 5-10 exchanges during the night.

Infuse equibalanceinto the peritoneal cavityonly.
Use equibalanceonly if the solution is clear and the container is not damaged.

equibalanceis presented as a double-chamber bag. Before use, the solutions contained in the two
compartments must be mixed as described.

Instructions for use
stay•safe system for continuous ambulatory peritoneal dialysis (CAPD)
First, warm the bag containing the solution to body temperature. This operation
must be performed using a dedicated warming device. The warming time for
2,000 ml bags with an initial temperature of 22 °C is approximately 120 minutes. More
and more detailed information is available in the warming device's instruction manual.
Do not use a microwave oven to warm the bag due to the risk of local overheating.
Once the solution is warmed, the bag exchange can be started.

1. Solution Preparation

 Check the heated bag (label, expiry date, clarity of the solution, absence of
damage to the bag and outer packaging, integrity of the seal).
 Place the bag on a rigid surface. 
Open the outer packaging of the bag and the disinfectant cap packaging. 
Wash your hands with an antibacterial product. 
Roll the bag, resting it on the protective packaging sheet, from one of the top edges until
the central heat seal opens. The solutions contained in the two chambers will mix
automatically. 
Then roll the bag from the top edge until the triangular lower seal opens
completely. 
Check that all the seals have opened completely. 
Check that the solution is clear and that the bag has no leaks.

2. Preparation for bag exchange

 Hang the solution bag in the highest hole of the bag holder pole, unroll the
infusion line of the bag containing the solution and position the DISCO in the organizer. After
unrolling the drainage bag line, hang the drainage bag in the lowest hole
of the bag holder pole. 
Position the catheter adapter in one of the two inserts of the organizer.  Position the new
disinfection cap in the other free insert. 
Disinfect your hands and remove the protective cap of the DISCO. 
Connect the catheter adapter to the DISCO.

3. Drainage

 Open the clamp on the extension. Drainage begins. 
Position 

4. Flushing

 At the end of the flushing, allow the fresh solution to flow into the drainage bag (approximately 5 seconds). 
Position 

5. Infusion

 Start the infusion by rotating the control switch towards the 
 Position 

6. Safety Position

 Close the catheter adapter by automatic insertion of the PIN into the catheter connector. 
Position 

• 7. Disconnection  Remove the protective cap from the new disinfection cap and screw it onto the old one.  Remove the catheter adapter from the DISCO and screw it onto the new disinfection cap.

8. Closing the DISCO

 Close the DISCO with the open end of the used disinfection cap, remaining in the right hole
of the organizer.

• 9. Checkthe transparency and weight of the drained dialysate and proceed with disposalif it appears clear. sleep system•safe for automated peritoneal dialysis (APD)

During automated peritoneal dialysis (APD), the solution is automatically heated
by the equipment.

sleep •safe system 3,000 ml

• 1. Solution preparation: see stay•safesystem
• 2. Unroll the infusion line of the bag.
• 3. Remove the protective cap.
• 4. Insert the bag connector into the appropriate locations on the sleep•safeequipment.
• 5. The bag is now ready for use with the sleep•safeset.

sleep •safe system 5,000 ml and 6,000 ml

• 1. Solution preparation  Check the bag containing the solution (label, expiration date, clarity of the solution, absence of damage to the bag and external packaging, integrity of the seal).  Place the bag on a rigid surface.  Open the protective packaging of the bag.  Wash your hands with an antibacterial product.  Extend the median seal and the bag connector.  Roll the bag, resting it on the protective packaging, from the end of the diagonal towards the bag connector. The median seal will now be open. 

Continue until the seal of the small chamber has opened. 
Check that all the seals have opened completely. 
Check that the solution is clear and that the bag has no leaks.

• 2. – 5.: see sleep•safe3,000 ml system

Safe •Lock System for automated peritoneal dialysis (APD)
During automated peritoneal dialysis (APD), the solution is automatically heated
by the equipment.

• 1. Solution preparation: see sleep•safe5,000 ml and 6,000 ml system
• 2. Remove the protective cap of the connector from the connection line
• 3. Connect the lines to the bag
• 4. Break the internal seal by bending the line and the PIN more than 90° on both sides
• 5. The bag is now ready for use. Each bag of solution must be used only once and any unused solution residue must be disposed of. After appropriate training, equibalance can be used independently at Your home. For this reason, it is necessary to verify that each step has been understood during training as well as strict adherence to the correct hygienic conditions to be used during bag exchange. Always check for any turbidity of the drained dialysate. See paragraph 2 If you use more equibalance than you should:If an excess of solution is infused into the peritoneal cavity, the excess can be easily drained. If you have used too many bags, contact your doctor as this could lead to dehydration and/or electrolyte imbalances.

If you forget to useequibalance
Try to reach the total volume of dialysate prescribed in 24 hours in order to avoid possible
health risks. If in doubt, check with your doctor.
If you have any questions about the use of this medicine, ask your doctor, pharmacist or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur in general following treatment with peritoneal dialysis:

Very common(may affect more than 1 in 10 people):

• inflammation of the peritoneum indicated by cloudy dialysate, abdominal pain, fever, general malaise or in very rare cases blood poisoning. Show the bag containing the dialysate fluid to your doctor in these cases
• inflammation of the skin in the catheter exit area or along the entire length of the catheter, recognizable by redness, swelling, pain, weeping, scabs
• abdominal wall hernia

Contact your doctor immediately if any of these side effects should occur.
Other side effects due to the treatment are:

Common(may affect up to 1 in 10 people):

• problems with infusion or drainage of the dialysate
• feeling of bloating or abdominal fullness
• shoulder pain

Uncommon(may affect up to 1 in 100 people):

• diarrhea
• constipation

Very rare(may affect up to 1 in 10,000 people):

• blood poisoning Not known(frequency cannot be estimated based on available data):
• difficulty breathing
• feeling unwell
• encapsulating peritoneal sclerosis, possible symptoms may include abdominal pain, abdominal distension or vomiting

The following side effects may occur when equibalance is used:

Very common, (may affect more than 1 in 10 people):

• potassium deficiency

Common(may affect up to 1 in 10 people):

• hypercalcemia if calcium intake is too high
• elevated blood sugar levels
• elevated blood fat levels
• weight gain

Uncommon(may affect up to 1 in 100 people):

• excessively low levels of body fluids, which are recognizable by rapid weight loss, low blood pressure, rapid pulse
• excessively high levels of body fluids, which are recognizable by fluid in the tissues and lungs, high blood pressure and difficulty breathing
• dizziness

Reporting of side effects
If you get any side effects, even those not listed in this leaflet, tell your doctor, pharmacist or nurse. You can also report side effects directly through
the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-
avverse. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store equibalance

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bag and the box after
Exp. The expiry date refers to the last day of that month.
Do not store at a temperature below 4 °C.
The ready-to-use solution must be used immediately, and in any case within a maximum of
24 hours from mixing.

6. Contents of the pack and other information

What containsequibalance
The active ingredients in 1 liter of ready-to-use solution are:
Calcium chloride dihydrate 0.2573 g
Sodium chloride 5.640 g
Sodium (S)-lactate solution
(3.925 g of sodium (S)-lactate)
7.85 g
Magnesium chloride hexahydrate 0.1017 g
Glucose monohydrate
(42.5 g of anhydrous glucose)
46.75 g
These amounts of active ingredients are equivalent to:
1.75 mmol/l of calcium, 134 mmol/l of sodium, 0.5 mmol/l of magnesium, 101.5 mmol/l of chloride, 35
mmol/l of lactate and 235.8 mmol/l of glucose.
The excipients are water for injections, hydrochloric acid, sodium hydroxide and sodium
hydrogen carbonate

Description of the appearance of equibalance and contents of the pack
The solution is clear and colorless.
The theoretical osmolarity of the ready-to-use solution is 511 mOsm/l, the pH is approximately 7.0.

equibalanceis available in a double-chamber bag. One chamber contains the alkaline solution of
sodium lactate while the other contains the acidic electrolytic solution containing glucose.

equibalanceis available in the following application systems and in the following pack sizes:

stay•safesleep•safeSafe•Lock
4 x 2,000 ml
4 x 2,500 ml
4 x 3,000 ml
4 x 3,000 ml
2 x 5,000 ml
2 x 6,000 ml
2 x 5,000 ml
2 x 6,000 ml
Not all pack sizes may be marketed.

Marketing Authorisation Holder
Fresenius Medical Care Italia S.p.A., Via Crema 8, 26020, Palazzo Pignano (Cremona), Italy

Manufacturer
Fresenius Medical Care Deutschland GmbH, Frankfurter Strasse 6-8, 66606 St. Wendel, Germany

This medicinal product is authorised in the member states of the EEA under the following name:
This medicinal product is authorised in the member states of the EEA under the following name:
B, NLbalance4.25 % glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

CZbalance4.25 % glucose, 1.75 mmol/l calcium,roztok pro peritoneální dialýzu

D, A, Lbalance4.25 % Glucose, 1.75 mmol/l Calcium,Peritonealdialyselösung

DKbalance4.25 % glucose, 1.75 mmol/l calcium,peritonealdialysev æ ske

Ebalance4.25 % glucosa, 1.75 mmol/l de calcio,solución para diálisis peritoneal

ESTbalance4.25 % glükoos, 1.75 mmol/l kaltsium,peritoneaaldialüüsilahus

FDialyse Péritonéale Continue Ambulatoire 3,solution pour dialyse péritonéale

FINbalance4.25 % glukoosi, 1.75 mmol/l kalsium,peritoneaalidialyysineste

GB, Mbalance4.25% glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

GR, CYbalance4.25 % γλυκόζη, 1.75 mmol/l ασβέστιο,Διάλυμα περιτοναϊκής διαπίδυσης (κάθαρσης)

Hbalance4,25 % glükóz, 1,75 mmol/l kalcium,peritoneális dializáló oldat

HRbalance4,25% glukoze, 1,75 mmol/l kalcija,otopina za peritonejsku dijalizu

Iequibalance4,25 % glucosio, 1,75 mmol/l calcio,soluzione per dialisi peritoneale

LTbalance4,25 % gliukozės, 1,75 mmol/l kalcio,pilvaplėvės ertmės dializės tirpalas

LVbalance4,25 % glikoze, 1,75 mmol/l kalcijs,šķīdums peritoneālai dialīzei

Nbalance4,25 % glukose, 1,75 mmol kalsium/l,peritonealdialysev æ ske

Pbalance4,25 % glucose, 1,75 mmol/l de cálcio,soluçăo para diálise peritoneal

PLbalance4,25 % z 4,25 % glukozą i wapniem 1,75 mmol/l,roztwór do dializy otrzewnowej

RObalance4,25 % glucoză, 1,75 mmol/l calciu,soluţie pentru dializă peritoneală

Sbalance4.25 % glucose, 1.75 mmol/l calcium,peritonealdialysvätska

SKbalance4.25 % glucose, 1.75 mmol/l calcium,roztok na peritoneálnu dialýzu

SLObalance42,5 mg/ml glukoze, 1,75 mmol/l kalcija,raztopina za peritonealno dializo
equibalance 2,3% glucosio, 1,75 mmol/l calcio, soluzione per dialisi peritoneale

contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor, pharmacist or nurse. See section 4.

Contents of this leaflet:

• 1. What equibalanceis and what it is used for
• 2. What you need to know before you use equibalance
• 3. How to use equibalance
• 4. Possible side effects
• 7. How to store equibalance
• 8. Contents of the pack and other information

1. What is equibalance and what is it used for

equibalance is used for blood purificationthrough the peritoneum in patients with
end-stage chronic renal failure. This type of blood purification is called peritoneal
dialysis.

2. What you need to know before using equibalance

Do not use equibalance 2.3% glucose, 1.75 mmol/l calcium:

• If your blood potassium level is very low
• If your blood calcium level is very high
• If you have a metabolic disorder known as lactic acidosis

Peritoneal dialysis should not be undertaken if you suffer from:
alterations in the abdominal regionsuch as:
surgical interventions or abdominal injuries,
burns,
extensive inflammatory conditions of the abdominal wall,
inflammation of the peritoneum,
exudative wounds that do not heal,
umbilical, inguinal or diaphragmatic hernias,
tumors in the abdomen or intestine
inflammatory bowel diseases,
intestinal obstruction
lung diseases, especially pneumonia
blood poisoning caused by bacteria
very high levels of lipids in the blood
in cases of accumulation of uremic toxins in the blood whose elimination cannot be effected
with dialysis
severe malnutrition and weight loss, especially if adequate intake is not possible
of foods containing proteins.

Warnings and precautions
Immediately inform your doctor

• if you have had a severe loss of electrolytes (salts)due to vomiting and/or diarrhea,
• If you suffer from enlarged kidneys(polycystic kidneys)
• If you suffer from inflammation of the peritoneum, recognizable by cloudy dialysate fluid and/or abdominal pain. Show the bag containing the dialysate fluid to your doctor.
• If you have severe abdominal pain, abdominal distension or vomiting. This may be a sign of encapsulating peritoneal sclerosis, a complication of peritoneal dialysis therapy that can be fatal.

During peritoneal dialysis, a loss of proteinsand water-soluble vitaminsmay occur. To avoid
imbalances, an adequate diet or the intake of supplements is recommended.
Your doctor will monitor your electrolyte (salt) level, kidney function, body weight and
nutritional status.
Due to the high glucose concentration, equibalance2.3% glucose, 1.75 mmol/l calcium must
be used with caution and under medical supervision.

Other medicines andequibalance
Tell your doctor or pharmacist if you are taking, have recently taken or might take
any other medicine.
Since peritoneal dialysis can affect the effects of other drugs, your doctor may change their
dosage, especially in the case of:

• drugs for heart problems, such as digoxin. The doctor will check the potassium levels in the blood and, if necessary, take appropriate measures.
• drugs that affect calcium levelssuch as those containing calcium or vitamin D.
• drugs that increase urine output, such as diuretics.
• drugstaken orally that lower blood sugar levels or insulin. Your blood sugar should be checked regularly. Diabetic patients may need an adjustment to their daily insulin dose.

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant or are planning to become pregnant, or if you are
breastfeeding, ask your doctor for advice before taking this medicine. There are no adequate
data on the use of equibalancein pregnant women or during breastfeeding. If
you are pregnant or breastfeeding, you can use equibalanceonly if your doctor considers it
absolutely necessary.
Driving and using machines
equibalancedoes not alter or alters negligibly the ability to drive vehicles or use
machinery.

3. How to use equibalance

Use this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, ask your doctor or pharmacist.
Your doctor will define the method, duration and frequency of use, the volume of solution and the time
of dwell in the peritoneal cavity.
If you experience tension in the abdominal region, your doctor may reduce the volume.

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Adults:the usual dose is 2,000-3,000 ml of solution four times a day depending on body
weight and renal function.
After 2-10 hours of dwell time, the solution is drained.

Children:the doctor will determine the required dialysis solution volume based on tolerance,
age, and the child's body surface area.
The recommended initial dose is 600-800 ml/m (up to 1,000 ml/m during the night) of body
surface area 4 times a day.

Automated Peritoneal Dialysis (APD)
For this dialysis, sleep•safeor Safe•Lock delivery systems are used. The exchange
of bags is automatically controlled by the equipment during the night.

• Adults: The usual prescription is 2,000 ml (maximum 3,000 ml) per exchange with 3-10 exchanges during the night and connection time to the equipment of 8-10 hours, and one or two exchanges during the day.
• Children: The volume per exchange should be 800-1,000 ml/m (up to 1,400 ml/m) of body surface area with 5-10 exchanges during the night.

Infuse equibalanceonly into the peritoneal cavity.
Use equibalanceonly if the solution is clear and the container is not damaged.

equibalanceis presented as a double-chamber bag. Before use, the solutions contained in the two
compartments must be mixed as described.

Instructions for use
stay•safesystem for continuous ambulatory peritoneal dialysis (CAPD)
First, warm the bag containing the solution to body temperature. This operation
must be performed using a special warming device. The warming time for
2,000 ml bags with an initial temperature of 22 °C is approximately 120 minutes. More
detailed information is available in the warming device's instruction manual.
Do not use a microwave oven to warm the bag due to the risk of local overheating.
Once the solution is warmed, the bag exchange can be started.

1. Preparation of the solution

 Check the heated bag (label, expiry date, clarity of the solution, absence of
damage to the bag and outer packaging, integrity of the seal).
 Place the bag on a rigid surface. 
Open the outer packaging of the bag and the disinfectant cap packaging. 
Wash your hands with an antibacterial product. 
Roll the bag, resting it on the protective packaging sheet, from one of the top edges until
the central heat seal opens. The solutions contained in the two chambers mix
automatically. 
Then roll the bag from the top edge until the triangular lower seal opens
completely. 
Check that all the seals have opened completely. 
Check that the solution is clear and that the bag has no leaks.

2. Preparation for bag exchange

 Hang the solution bag in the highest hole of the bag holder pole, unroll the
infusion line of the bag containing the solution and position the DISCO in the organizer. After
unrolling the line of the drainage bag, hang the drainage bag in the lowest hole
of the bag holder pole. 
Position the catheter adapter in one of the two inserts of the organizer.  Position the new
disinfection cap in the other free insert. 
Disinfect your hands and remove the protective cap of the DISCO. 
Connect the catheter adapter to the DISCO.

3. Drainage

 Open the clamp on the extension set. Drainage begins. 
Position 

4. Flushing

 At the end of the flushing, allow the fresh solution to flow into the drainage bag (approximately 5 seconds). 
Position 

6. Infusion

 Start the infusion by rotating the control switch towards the 
Position 

9. Safety Position

 Close the catheter adapter by automatic insertion of the PIN into the catheter connector. 
Position 

10. Disconnection

 Remove the protective cap from the new disinfection cap and screw it onto the old one.

Remove the catheter adapter from the DISCO and screw it onto the new disinfection cap.

11. DISCO Closure

 Close the DISCO with the open end of the used disinfection cap, which remains in the right hole of the organizer.

• 10. Checkthe transparency and weight of the drained dialysate and proceed with disposalif it appears clear. sleep•safeSystemfor automated peritoneal dialysis (APD)

During automated peritoneal dialysis (APD), the solution is automatically heated by the device.

sleepsafe System 3,000 ml

• 6. Solution preparation: see stay•safesystem
• 7. Unroll the infusion line of the bag.
• 8. Remove the protective cap.
• 9. Insert the bag connector into the appropriate seats on the sleep•safedevice.
• 10. The bag is now ready for use with the sleep•safeset.

sleep•safeSystem 5,000 ml and 6,000 ml

• 1. Solution preparation  Check the bag containing the solution (label, expiry date, clarity of the solution, absence of damage to the bag and outer packaging, integrity of the seal).  Place the bag on a rigid surface.  Open the protective packaging of the bag.  Wash your hands with an antibacterial product.  Spread out the median weld and the bag connector.  Roll the bag, resting it on the protective packaging, from the end of the diagonal towards the bag connector. The median weld will now be open.  Continue until the weld of the small chamber is also open.  Check that all welds have opened completely.  Check that the solution is clear and that the bag has no leaks.
• 2. – 5.: see sleep•safe3,000 ml system Safe System•Lock for automated peritoneal dialysis (APD)During automated peritoneal dialysis (APD), the solution is automatically heated by the device.
• 6. Solution preparation: see sleep•safe5,000 ml and 6,000 ml system
• 7. Remove the protective cap of the connector from the connection line
• 8. Connect the lines to the bag
• 9. Break the internal seal by bending the line and PIN more than 90° on both sides
• 10. The bag is now ready for use

Each solution bag must be used only once and any unused solution residue must be disposed of.
After appropriate training, equibalance can be used independently at your home. For this reason, it is necessary to verify that each step has been understood during training as well as strict adherence to the correct hygienic conditions to be used during bag exchange.
Always check for any turbidity of the drained dialysate. See paragraph 2

If you use moreequibalancethan you should
If an excess of solution is infused into the peritoneal cavity, the excess can be easily drained. If you have used too many bags, contact your doctor as this may lead to dehydration and/or electrolyte imbalances.

If you forget to useequibalance
Try to reach the total volume of dialysate prescribed in 24 hours in order to avoid possible health risks. If in doubt, check with your doctor.
If you have any questions about the use of this medicine, ask your doctor, pharmacist or nurse.

5. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The following side effects may occur in general following treatment with peritoneal dialysis:

Very common(may affect more than 1 in 10 people):

• inflammation of the peritoneum indicated by the presence of cloudy dialysate, abdominal pain, fever, general malaise or, in very rare cases, blood poisoning. Show the bag containing the dialysate fluid to your doctor in these cases
• inflammation of the skin at the catheter exit site or along the entire length of the catheter, recognizable by redness, swelling, pain, weeping, scabs
• abdominal wall hernia

Contact your doctor immediately if any of these side effects should occur.
Other side effects due to the treatment are:

Common(may affect up to 1 in 10 people):

• problems with infusion or drainage of the dialysate
• feeling of bloating or abdominal fullness
• shoulder pain

Uncommon(may affect up to 1 in 100 people):

• diarrhea
• constipation

Very rare(may affect up to 1 in 10,000 people):

• blood poisoning

Not known(frequency cannot be estimated from available data):

• difficulty breathing
• feeling unwell
• encapsulating peritoneal sclerosis, possible symptoms may include abdominal pain, abdominal distension or vomiting

The following side effects may occur when equibalance is used:

Very common, (may affect more than 1 in 10 people):

• potassium deficiency Common(may affect up to 1 in 10 people):
• hypercalcemia if calcium intake is too high
• elevated blood sugar levels
• elevated blood fat levels,
• weight gain

Uncommon(may affect up to 1 in 100 people):

• excessively low levels of body fluids, which are recognizable by rapid weight loss, low blood pressure, rapid pulse
• excessively high levels of body fluids, which are recognizable by fluid in the tissues and lungs, high blood pressure and difficulty breathing
• dizziness

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. You can also report side effects directly through
the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-
avverse. By reporting side effects you can help provide more information on the safety of this medicine.

5. How to store equibalance

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the bag and the carton after
Exp. The expiry date refers to the last day of that month.
Do not store at a temperature below 4 °C.
The ready-to-use solution must be used immediately, and in any case within a maximum of
24 hours from mixing.

6. Contents of the pack and other information

What containsequibalance
The active ingredients in 1 litre of ready-to-use solution are:
Calcium chloride dihydrate 0.2573 g
Sodium chloride 5.640 g
Sodium (S)-lactate solution
(3.925 g of sodium (S)-lactate)
7.85 g
Magnesium chloride hexahydrate 0.1017 g
Glucose monohydrate
(22.73 g of anhydrous glucose)
25.0 g
These amounts of active ingredients are equivalent to:
1.75 mmol/l of calcium, 134 mmol/l of sodium, 0.5 mmol/l of magnesium, 101.5 mmol/l of chloride, 35
mmol/l of lactate and 126.1 mmol/l of glucose.
The excipients are water for injections, hydrochloric acid, sodium hydroxide and sodium
hydrogen carbonate

Description of the appearance of equibalance and contents of the pack
The solution is clear and colourless.
The theoretical osmolarity of the ready-to-use solution is 401 mOsm/l, the pH is approximately 7.0.

equibalanceis available in a double-chamber bag. One chamber contains the alkaline solution of
sodium lactate while the other contains the acidic electrolytic solution containing glucose.

equibalanceis available in the following application systems and pack sizes:

stay•safesleep•safeSafe•Lock
4 x 2,000 ml
4 x 2,500 ml
4 x 3,000 ml
4 x 3,000 ml
2 x 5,000 ml
2 x 6,000 ml
2 x 5,000 ml
2 x 6,000 ml
Not all pack sizes may be marketed.

Marketing Authorisation Holder
Fresenius Medical Care Italia S.p.A., Via Crema 8, 26020, Palazzo Pignano (Cremona), Italy

Manufacturer
Fresenius Medical Care Deutschland GmbH, Frankfurter Strasse 6-8, 66606 St. Wendel, Germany

This medicinal product is authorised in the member states of the EEA with the following name:
This medicinal product is authorised in the member states of the EEA with the following name:
B, NLbalance2.3 % glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

CZbalance2.3 % glucose, 1.75 mmol/l calcium,roztok pro peritoneální dialýzu

D, A, Lbalance2.3 % Glucose, 1.75 mmol/l Calcium,Peritonealdialyselösung

DKbalance2.3 % glucose, 1.75 mmol/l calcium,peritonealdialysevæske

Ebalance2.3 % glucosa, 1.75 mmol/l de calcio,solución para diálisis peritoneal

ESTbalance2.3 % glükoos, 1.75 mmol/l kaltsium,peritoneaaldialüüsilahus

FDialyse Péritonéale Continue Ambulatoire 4,solution pour dialyse péritonéale

FINbalance2.3 % glukoosi, 1.75 mmol/l kalsium,peritoneaalidialyysineste

GB, Mbalance2.3% glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

GR, CYbalance2.3 % γλυκόζη, 1.75 mmol/l ασβέστιο,Διάλυμα περιτοναϊκής διαπίδυσης (κάθαρσης)

Hbalance2,3 % glükóz, 1,75 mmol/l kalcium,peritoneális dializáló oldat

HRbalance2,3% glukoze, 1,75 mmol/l kalcija,otopina za peritonejsku dijalizu

Iequibalance2,3 % glucosio, 1,75 mmol/l calcio,soluzione per dialisi peritoneale

LTbalance2,3 % gliukozės, 1,75 mmol/l kalcio,pilvaplėvės ertmės dializės tirpalas

LVbalance2,3 % glikoze, 1,75 mmol/l kalcijs,šķīdums peritoneālai dialīzei

Nbalance2,3 % glukose, 1,75 mmol kalsium/l,peritonealdialysevæske

Pbalance2,3 % glucose, 1,75 mmol/l de cálcio,soluçăo para diálise peritoneal

PLbalance2,3 % z 2,3 % glukozą i wapniem 1,75 mmol/l,roztwór do dializy otrzewnowej

RObalance2,3 % glucoză, 1,75 mmol/l calciu,soluţie pentru dializă peritoneală

Sbalance2.3 % glucose, 1.75 mmol/l calcium,peritonealdialysvätska

SKbalance2.3 % glucose, 1.75 mmol/l calcium,roztok na peritoneálnu dialýzu

SLObalance23 mg/ml glukoze, 1,75 mmol/l kalcija,raztopina za peritonealno dializo
equibalance 1,5% glucosio, 1,75 mmol/l calcio, soluzione per dialisi peritoneale

contains important information for you.

• Keep this leaflet. You may need to read it again.
• If you have any questions, ask your doctor, pharmacist or nurse.
• This medicine has been prescribed for you only. Do not pass it on to others, even if their symptoms are the same as yours, as it could be harmful.
• If you get any side effects, even those not listed in this leaflet, tell your doctor, pharmacist or nurse. See section 4.

Contents of this leaflet:

• 1. What equibalanceis and what it is used for
• 2. What you need to know before you use equibalance

• 3. How to use equibalance
• 4. Possible side effects
• 9. How to store equibalance
• 10. Contents of the pack and other information

1. What is equibalance and what is it used for

equibalanceis used for blood purificationthrough the peritoneum in patients with
end-stage chronic renal failure. This type of blood purification is called peritoneal
dialysis.

2. What you need to know before using equibalance

Do not use equibalance 1.5% glucose, 1.75 mmol/l calcium:

• If your potassium level in the blood is very low
• If your calcium level in the blood is very high
• If you have a metabolic disorder known as lactic acidosis

Peritoneal dialysis should not be undertaken if you suffer from:
alterations in the abdominal regionsuch as:
surgical interventions or abdominal injuries,
burns,
extensive inflammatory conditions of the abdominal wall,
inflammation of the peritoneum,
exudative wounds that do not heal,
umbilical, inguinal or diaphragmatic hernias,
tumors in the abdomen or intestine
inflammatory bowel diseases,
intestinal obstruction
lung diseases, especially pneumonia
blood poisoning caused by bacteria
very high levels of lipids in the blood
in cases of accumulation of uremic toxins in the blood whose elimination cannot be effected
with dialysis
severe malnutrition and weight loss, especially if adequate intake of
protein-containing foods is not possible.

Warnings and precautions
Immediately inform your doctor

• if you have had a severe loss of electrolytes (salts)due to vomiting and/or diarrhea,
• If you suffer from enlarged kidneys(polycystic kidneys)
• If you suffer from inflammation of the peritoneum, recognizable by turbid dialysate fluid and/or abdominal pain. Show the bag containing the dialysate fluid to your doctor.
• If you have severe abdominal pain, abdominal distension or vomiting. This may be a sign of encapsulating peritoneal sclerosis, a complication of peritoneal dialysis therapy that can be fatal.

During peritoneal dialysis, a loss of proteinsand water-soluble vitaminsmay occur. To avoid
imbalances, an adequate diet or the intake of supplements is recommended.
Your doctor will monitor your electrolyte (salt) levels, kidney function, body weight and
nutritional status.

Other medicines andequibalance
Inform your doctor or pharmacist if you are taking, have recently taken or might take
any other medicine.
Since peritoneal dialysis can affect the effects of other drugs, your doctor may change their
dosage, especially in the case of:

• drugs for heart problems, such as digoxin. The doctor will check the potassium levels in the blood and, if necessary, take appropriate measures.
• drugs that affect calcium levelssuch as those containing calcium or vitamin D.
• drugs that increase urine excretion, such as diuretics.
• drugstaken orally that lower blood sugar levelsor insulin. Your blood sugar should be checked regularly. Diabetic patients may need an adjustment of their daily insulin dose.

Pregnancy and breastfeeding
If you are pregnant, suspect you are pregnant, or are planning a pregnancy, or if you are breastfeeding
with breast milk, ask your doctor for advice before taking this medicine. There are no adequate
data on the use of equibalancein pregnant women or during breastfeeding. If
you are pregnant or breastfeeding, you can use equibalance only if your doctor considers it
absolutely necessary.

Driving and operating machinery
equibalancedoes not alter or negligibly alters the ability to drive vehicles or operate
machinery.

3. How to use equibalance

Use this medicine following exactly the instructions of your doctor or pharmacist. If you have
any doubts, ask your doctor or pharmacist.
Your doctor will define the method, duration and frequency of use, the volume of solution and the dwell
time in the peritoneal cavity.
If you experience tension in the abdominal region, your doctor may reduce the volume.

Continuous Ambulatory Peritoneal Dialysis (CAPD)
Adults:the usual dose is 2,000-3,000 ml of solution four times a day depending on body
weight and renal function.
After 2-10 hours of dwell time, the solution is drained.

Children:the doctor will determine the required dialysis solution volume based on tolerance,
age, and the child's body surface area.
The recommended initial dose is 600-800 ml/m (up to 1,000 ml/m at night) of body
surface area 4 times a day.

Automated Peritoneal Dialysis (APD)
For this dialysis, sleep•safeor Safe•Lock delivery systems are used. The exchange
of bags is automatically controlled by the equipment during the night.

• Adults: The usual prescription is 2,000 ml (maximum 3,000 ml) per exchange with 3-10 exchanges during the night and connection time to the equipment of 8-10 hours, and one or two exchanges during the day.
• Children: The volume per exchange should be 800-1,000 ml/m (up to 1,400 ml/m) of body surface area with 5-10 exchanges during the night.

Infuse equibalanceinto the peritoneal cavityonly.
Use equibalanceonly if the solution is clear and the container is not damaged.

equibalanceis presented as a double-chamber bag. Before use, the solutions contained in the two
compartments must be mixed as described.

Instructions for use
stay•safe system for continuous ambulatory peritoneal dialysis (CAPD)
First, warm the bag containing the solution to body temperature. This operation
must be performed using a special warming device. The warming time for
2,000 ml bags with an initial temperature of 22 °C is approximately 120 minutes. More
detailed information is available in the warming device's instruction manual.
Do not use a microwave oven to warm the bag due to the risk of local overheating.
Once the solution is warmed, the bag exchange can be started.

1. Preparation of the solution

 Check the heated bag (label, expiry date, clarity of the solution, absence of
damage to the bag and outer packaging, integrity of the seal).
 Place the bag on a rigid surface. 
Open the outer packaging of the bag and the disinfectant cap packaging. 
Wash your hands with an antibacterial product. 
Roll the bag, resting it on the protective packaging sheet, from one of the top edges until
the central heat seal opens. The solutions contained in the two chambers will mix
automatically. 
Then roll the bag from the top edge until the triangular lower seal opens
completely. 
Check that all the seals have opened completely. 
Check that the solution is clear and that the bag has no leaks.

2. Preparation for sac exchange

 Hang the solution bag in the highest hole of the bag holder pole, unroll the infusion line
of the bag containing the solution and position the DISCO in the organizer. After unrolling the drainage bag line, hang the drainage bag in the lowest hole of the bag holder pole. 
Position the catheter adapter in one of the two inserts of the organizer.  Position the new
disinfection cap in the other free insert. 
Disinfect your hands and remove the protective cap of the DISCO. 
Connect the catheter adapter to the DISCO.

3. Drainage

 Open the clamp on the extension set. Drainage begins. 
Position 

4. Flushing

 At the end of the flushing, allow the fresh solution to flow into the drainage bag (approximately 5 seconds). 
Position 

7. Infusion

 Start the infusion by rotating the control switch towards the 
Position 

12. Safety position

 Close the catheter adapter by automatic insertion of the PIN into the catheter connector. 
Position 

13. Disconnection

 Remove the protective cap from the new disinfection cap and screw it onto the old one. 
Remove the catheter adapter from the DISCO and screw it onto the new disinfection cap.

14. DISCO Closure

 Close the DISCO with the open end of the used disinfection cap, remaining in the right hole
of the organizer.

• 11. Checkthe transparency and weight of the drained dialysateand proceed with disposalif it appears clear. sleep•safesystemfor automated peritoneal dialysis (APD)

During automated peritoneal dialysis (APD), the solution is automatically heated
by the equipment.

sleep•safesystem3,000 ml

• 11. Solution preparation: see stay•safe system
• 12. Unroll the infusion line of the bag.
• 13. Remove the protective cap.
• 14. Insert the bag connector into the appropriate seats on the sleep•safeequipment.
• 15. The bag is now ready for use with the sleep•safeset.

sleep•safesystem5,000 ml and 6,000 ml

• 1. Solution preparation  Check the bag containing the solution (label, expiry date, clarity of the solution, absence of damage to the bag and outer packaging, integrity of the seal).  Place the bag on a rigid surface.  Open the protective packaging of the bag.  Wash your hands with an antibacterial product.  Extend the median weld and the bag connector.  Roll the bag, resting it on the protective packaging, from the end of the diagonal towards the bag connector. The median weld will now be open.  Continue until the weld of the small chamber has opened.  Check that all welds have opened completely.  Check that the solution is clear and that the bag has no leaks.
• 2. – 5.: see sleep•safe 3,000 ml system SafeSystem•Lock for automated peritoneal dialysis (APD)During automated peritoneal dialysis (APD), the solution is automatically heated by the equipment.
• 11. Solution preparation: see sleep•safe 5,000 ml and 6,000 ml system
• 12. Remove the protective cap of the connector from the connection line
• 13. Connect the lines to the bag
• 14. Break the internal seal by bending the line and PIN more than 90° on both sides
• 15. The bag is now ready for use Each bag of solution must be used only once and any residual unused solution must be disposed of. After appropriate training, equibalance can be used independently at Your home. For this reason, it is necessary to verify that each step has been understood during training as well as the strict observance of the correct hygienic conditions to be used during the exchange of bags. Always check for any turbidity of the drained dialysate. See paragraph 2 If you use moreequibalancethan you should

If an excess of solution is infused into the peritoneal cavity, the excess can be easily
drained. If you have used too many bags, contact your doctor as this may lead to states
of dehydration and/or electrolyte imbalances.

If you forget to useequibalance
Try to reach the total volume of dialysate prescribed in 24 hours in order to avoid possible
health risks. If in doubt, check with your doctor.
If you have any questions about the use of this medicine, ask your doctor, pharmacist or nurse.

6. Possible side effects

Like all medicines, this medicine can cause side effects, although not everyone gets them.
The following side effects may occur in general following treatment with peritoneal dialysis:

Very common(may affect more than 1 in 10 people):

• inflammation of the peritoneum indicated by the presence of cloudy dialysate, abdominal pain, fever, general malaise or in very rare cases blood poisoning. Show the bag containing the dialysate fluid to your doctor in these cases
• inflammation of the skin in the catheter exit area or along the entire length of the catheter, recognizable by redness, swelling, pain, tearing, scabs
• abdominal wall hernia

Contact your doctor immediately if any of these side effects should occur.
Other side effects due to treatment are:

Common(may affect up to 1 in 10 people):

• problems with infusion or drainage of the dialysate
• feeling of bloating or abdominal fullness
• shoulder pain

Uncommon(may affect up to 1 in 100 people):

• diarrhea
• constipation

Very rare(may affect up to 1 in 10,000 people):

• blood poisoning

Not known(frequency cannot be estimated from available data):

• difficulty breathing
• feeling unwell
• encapsulating peritoneal sclerosis, possible symptoms may include abdominal pain, abdominal distension or vomiting

The following side effects may occur when equibalanceis used:

Very common, (may affect more than 1 in 10 people):

• potassium deficiency

Common(may affect up to 1 in 10 people):

• hypercalcemia if calcium intake is too high
• elevated blood sugar levels
• elevated blood fat levels,
• weight gain Uncommon(may affect up to 1 in 100 people):
• excessively low levels of body fluids, which are recognizable by rapid weight loss, low blood pressure, rapid pulse
• excessively high levels of body fluids, which are recognizable by fluid in the tissues and lungs, high blood pressure and difficulty breathing
• dizziness

Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. You can also report side effects directly through
the national reporting system at https://www.aifa.gov.it/content/segnalazioni-reazioni-
avverse. By reporting side effects you can help provide more information on the
safety of this medicine.

5. How to store equibalance

Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is reported on the bag and on the box after
Exp. The expiry date refers to the last day of that month.
Do not store at a temperature below 4 °C.
The ready-to-use solution must be used immediately, and in any case within a maximum of
24 hours from mixing.

6. Contents of the pack and other information

What containsequibalance
The active ingredients in 1 liter of ready-to-use solution are:

These amounts of active ingredients are equivalent to:
1.75 mmol/l of calcium, 134 mmol/l of sodium, 0.5 mmol/l of magnesium, 101.5 mmol/l of chloride, 35
mmol/l of lactate and 83.2 mmol/l of glucose.
The excipients are water for injections, hydrochloric acid, sodium hydroxide and sodium
hydrogen carbonate

Description of the appearance ofequibalanceand contents of the pack
The solution is clear and colorless.
The theoretical osmolarity of the ready-to-use solution is 358 mOsm/l, the pH is about 7.0.

equibalanceis available in a double-chamber bag. One chamber contains the alkaline solution of
sodium lactate while the other the acidic electrolytic solution containing glucose.

equibalanceis available in the following application systems and packagings:

stay•safesleep•safeSafe•Lock
4 x 2,000 ml
4 x 2,500 ml
4 x 3,000 ml
4 x 3,000 ml
2 x 5,000 ml
2 x 6,000 ml
2 x 5,000 ml
2 x 6,000 ml
Not all pack sizes may be marketed.

Marketing Authorisation Holder
Fresenius Medical Care Italia S.p.A., Via Crema 8, 26020, Palazzo Pignano (Cremona), Italy

Manufacturer
Fresenius Medical Care Deutschland GmbH, Frankfurter Strasse 6-8, 66606 St. Wendel, Germany

This medicinal product is authorised in the member states of the EEA with the following name:
This medicinal product is authorised in the member states of the EEA with the following name:
B, NLbalance1.5 % glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

CZbalance1.5 % glucose, 1.75 mmol/l calcium,roztok pro peritoneální dialýzu

D, A, Lbalance1.5 % Glucose, 1.75 mmol/l Calcium,Peritonealdialyselösung

DKbalance1.5 % glucose, 1.75 mmol/l calcium,peritonealdialysev æ ske

Ebalance1.5 % glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

ESTbalance1.5 % glucose, 1.75 mmol/l calcium,peritoneaaldialüüsilahus

FContinuous Ambulatory Peritoneal Dialysis 2,solution for peritoneal dialysis

FINbalance1.5 % glucose, 1.75 mmol/l calcium,peritoneaalidialyysineste

GB, Mbalance1.5% glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

GR, CYbalance1.5 % glucose, 1.75 mmol/l calcium,Περιτοναϊκό διάλυμα διάλυσης (κάθαρσης)

Hbalance1,5 % glükóz, 1,75 mmol/l kalcium,peritoneális dializáló oldat

HRbalance1.5% glukoze, 1.75 mmol/l kalcija,otopina za peritonejsku dijalizu

Iequibalance1.5 % glucose, 1.75 mmol/l calcium,solution for peritoneal dialysis

LTbalance1.5 % gliukozės, 1.75 mmol/l kalcio,pilvaplėvės ertmės dializės tirpalas

LVbalance1.5 % glikoze, 1.75 mmol/l kalcijs,šķīdums peritoneālai dialīzei

Nbalance1.5 % glukose, 1.75 mmol kalsium/l,peritonealdialysev æ ske

Pbalance1.5 % glucose, 1.75 mmol/l calcium,soluçăo para diálise peritoneal

PLbalance1.5 % z 1.5 % glukozą i wapniem 1.75 mmol/l,roztwór do dializy otrzewnowej

RObalance1.5 % glucose, 1.75 mmol/l calcium,soluţie pentru dializă peritoneală

Sbalance1.5 % glucose, 1.75 mmol/l calcium,peritonealdialysvätska

SKbalance1.5 % glucose, 1.75 mmol/l calcium,roztok na peritoneálnu dialýzu

SLObalance15 mg/ml glukoze, 1.75 mmol/l kalcija,raztopina za peritonealno dializo